Salta al contenuto
Brugada Syndrome

Brugada, or not Brugada, that is the question

  • Home
  • Perché questo sito
  • News
  • Disclaimer
  • Info e link utili
  • Contatti
  • itItaliano (Italiano)
  • Home
  • Perché questo sito
  • News
  • Disclaimer
  • Info e link utili
  • Contatti
  • itItaliano (Italiano)

Ultime pubblicazioni sulla Sindrome del QT Lungo

  • Left cardiac sympathetic denervation in children with Jervell Lange-Nielsen syndrome and drug refractory torsades - A case series
    Pubblicato il: 20-09-2023
  • Rapid changes of mRNA expressions of cardiac ion channels affected by Torsadogenic drugs influence susceptibility of rat hearts to arrhythmias induced by Beta-Adrenergic stimulation
    Pubblicato il: 16-09-2023
  • Estimating the Probability of Early Afterdepolarizations and Predicting Arrhythmic Risk associated with Long QT Syndrome Type 1 Mutations
    Pubblicato il: 14-09-2023
  • Family long QT syndrome type 2 associated with <em>KCNH2</em> gene mutation: aborted sudden cardiac death
    Pubblicato il: 13-09-2023
  • 4-phenylbutyric acid re-trafficking hERG/G572R channel protein by modulating the endoplasmic reticulum stress-associated chaperones and endoplasmic reticulum-associated degradation gene
    Pubblicato il: 11-09-2023
  • Corrected QT Interval (QTc) Diagnostic App for the Oncological Routine: Development Study
    Pubblicato il: 11-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle
    Pubblicato il: 09-09-2023
  • Cardiovascular Screening before Sports Participation: Results of 11487 Children
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
    Pubblicato il: 04-09-2023
  • Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant
    Pubblicato il: 03-09-2023
  • Clinical and Genetic Features of Korean Inherited Arrhythmia Probands
    Pubblicato il: 01-09-2023
  • Total Intravenous Anaesthesia for Laparoscopic Cholecystectomy in a Patient With Congenital Long QT Syndrome: A Case Report
    Pubblicato il: 01-09-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
  • Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±)
    Pubblicato il: 31-08-2023
Older posts

Segui la mia pagina Facebook

[custom-facebook-feed locale="it_IT"]

Cerca

Tweets sulla Sindrome di Brugada

Registrati al sito

Inviami i nuovi articoli via email

Archivi

  • Settembre 2022
  • Marzo 2020
  • Settembre 2019
  • Luglio 2019
  • Aprile 2019
  • Dicembre 2018
  • Novembre 2018
  • Luglio 2018
  • Giugno 2018

Articoli recenti

  • Sindrome di Brugada: Le nuove linee guida ESC 2022

    Settembre 24, 2022

  • Brugada syndrome: the scientific uncertainties, the certainties, and the repeated exultation of the web.

    Febbraio 16, 2021

  • Awareness of the Brugada

    Febbraio 16, 2021

  • Brugada Phobia at the Sudden Cardiac Death conference

    Febbraio 15, 2021

  • COVID-19 e le sindromi aritmiche geneticamente determinate

    Marzo 28, 2020

Commenti recenti

  • daniele

    "sono stato seguito dal prof Nava per anni qui a padova, persona fantastica ..."

  • Elio Catapano

    "Mi fa piacere! Grazie "

  • Elio Catapano

    "Grazie "

  • FIORENZA FARNE’

    "CONDIVIDO COMPLETAMENTE L'ARTICOLO "

  • federica

    "Illuminante e incoraggiante, grazie! Federica "

  • Elio Catapano

    "Dr. Martini, un grazie con GRANDE Stima! "

  • BORTOLO MARTINI

    "superlativo! "

  • Sara

    "Yo estoy en esos bloqueos y con problema psicológico por el Brugada. "

  • Bortolo martini

    "Non solo scienza ma molti soldi governano la medicina "

  • Elio Catapano

    "La ringrazio per il feedback positivo e per il suggerimento: visto che ci ..."

Seguimi

Follow by Email
Facebook
Facebook
fb-share-icon
Twitter
Visit Us
Follow Me
Tweet

Seguimi

Follow by Email
Facebook
Facebook
fb-share-icon
Twitter
Visit Us
Follow Me
Tweet

Powered by WordPress & Theme by Anders Norén

  • itItaliano